Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Qurient initiates phase II study of telacebec in moderate COVID-19

Aug. 5, 2021

New study is both reality check and shot in the arm for SARS-CoV-2 drug repurposing

Aug. 4, 2021

Phase I/II trial cleared to begin in Singapore with ARCT-154 and ARCT-165 for SARS-CoV-2

Aug. 4, 2021

Telmisartan reduces morbidity and mortality in hospitalized patients with COVID-19

Aug. 4, 2021

CTA approved in Vietnam for phase I/II/III study of SARS-CoV-2 vaccine ARCT-154

Aug. 3, 2021

Intranasal vaccination with ChAdOx1 nCoV-19 reduces viral shedding in preclinical models

Aug. 3, 2021

Vaxart's IND application for S-only oral tablet COVID-19 vaccine cleared in U.S.

Aug. 3, 2021

Evolutionary modeling warns of COVID-19 vaccine resistance

Aug. 2, 2021

Deuterated GC-376 variants show efficacy in model of SARS-CoV-2 infection

Aug. 2, 2021

Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B

Aug. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...